It now seems technically feasible to culture human embryos beyond the “fourteen‐day limit,” which has the potential to increase scientific understanding of human development and perhaps improve infertility treatments. Robust stakeholder engagement preceded adoption of the fourteen‐day limit and should arguably be part of efforts to reassess it, write the authors.
Kirstin R.W. Matthews, Ana S. Iltis, Daniel S. Wagner, Nuria Gallego Marquez, Jason Scott Robert, Inmaculada de Melo-Martín, Marieke Bigg, Sarah Franklin, Soren Holm, Ingrid Metzler, Matteo A. Molè, Jochen Taupitz, Giuseppe Testa, Jeremy SugarmanFebruary 26, 2021
This study leverages validated patient-reported outcomes measures to analyze the association between "financial toxicity" and quality of life and satisfaction among women undergoing ablative breast cancer surgery. Journal of the American College of Surgeons
Anaeze C. Offodile II, Christopher J. Coroneos, Yu-Li Lin, Chris Sidey-Gibbons, Malke Asaad, Brian Chin, Stefanos Boukovalas, Margaret S. Roubaud, Makesha Miggins, Donald P. BaumannDecember 21, 2020
Existing innovation in outcomes measurement and resource management, coupled with the competitive pressures of Covid-19, create a unique window for value creation within surgical care, the authors write. Read their article in the Annals of Surgery.
Anaeze C. Offodile II, Kushal T. Kadakia, Lee Fleisher, C.J. Stimson, Thomas AloiaJuly 26, 2020
In this study, the authors found that deployment of a cost feedback tool using behavioral economics principles resulted in a marked decrease in operating room spending without negatively affecting the complication rate. Journal of the American College of Surgeons: http://bit.ly/39jaRO8
The authors aim to construct a value-based care framework for reconstructive surgery using post-mastectomy reconstruction as an organizing element. Breast Cancer Research and Treatment.
The authors examine the relationship between market competition and the use of surgical services for cancer to test the theory that market competition promotes patient access and health care delivery.
Marcelo Cerullo, Clara Lee, Anaeze C. Offodile IIDecember 1, 2018
The authors discuss the origins of bundled payments as an emerging alternative payment model in the health care industry and examine its application and potential for expansion. Annals of Surgical Oncology: http://bit.ly/2OMorOX
The connection between Texas H.B. 810, which allows clinics to provide investigational stem cell treatments to certain patients, and a deregulation movement to increase patient access to unproven stem cell treatments is described in this report.